- Home
- STBA vs IMCR Comparison
STBA vs IMCR Comparison
Compare STBA & IMCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STBA
- IMCR
- Stock Information
- Founded
- STBA 1902
- IMCR 2008
- Country
- STBA United States
- IMCR United Kingdom
- Employees
- STBA N/A
- IMCR N/A
- Industry
- STBA Major Banks
- IMCR Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- STBA Finance
- IMCR Health Care
- Exchange
- STBA Nasdaq
- IMCR Nasdaq
- Market Cap
- STBA 1.5B
- IMCR 1.5B
- IPO Year
- STBA N/A
- IMCR 2021
- Fundamental
- Price
- STBA $37.38
- IMCR $29.02
- Analyst Decision
- STBA Hold
- IMCR Buy
- Analyst Count
- STBA 1
- IMCR 13
- Target Price
- STBA $41.00
- IMCR $65.18
- AVG Volume (30 Days)
- STBA 190.5K
- IMCR 323.9K
- Earning Date
- STBA 01-30-2025
- IMCR 02-26-2025
- Dividend Yield
- STBA 3.64%
- IMCR N/A
- EPS Growth
- STBA N/A
- IMCR N/A
- EPS
- STBA 3.51
- IMCR N/A
- Revenue
- STBA $386,292,000.00
- IMCR $296,312,000.00
- Revenue This Year
- STBA N/A
- IMCR $28.91
- Revenue Next Year
- STBA $1.52
- IMCR $12.65
- P/E Ratio
- STBA $10.65
- IMCR N/A
- Revenue Growth
- STBA N/A
- IMCR 25.09
- 52 Week Low
- STBA $28.83
- IMCR $27.69
- 52 Week High
- STBA $45.79
- IMCR $76.98
- Technical
- Relative Strength Index (RSI)
- STBA 41.43
- IMCR 43.45
- Support Level
- STBA $36.75
- IMCR $28.22
- Resistance Level
- STBA $38.21
- IMCR $30.77
- Average True Range (ATR)
- STBA 0.97
- IMCR 1.34
- MACD
- STBA 0.08
- IMCR 0.03
- Stochastic Oscillator
- STBA 58.18
- IMCR 23.32
About STBA S&T Bancorp Inc.
S&T Bancorp Inc is a bank holding company. The company operates in five markets including Western Pennsylvania, Eastern Pennsylvania, Northeast Ohio, Central Ohio and Upstate New York. It has one reporting unit, Community Banking. The company provides financial services with retail and commercial banking products, cash management services, trust and brokerage services. The company earns revenue from interest on loans and securities and fees charged for financial services provided to its customers.
About IMCR Immunocore Holdings plc
Immunocore Holdings PLC is a late-stage biotechnology company engaged in the development of a novel class of TCR bispecific immunotherapies for the treatment of cancer, infectious and autoimmune diseases. Its geographical segments are the United Kingdom and the United States, of which the majority of its revenue comes from the United States.